Medications & Supplements/Prescription Drugs

Clindamycin HCl Capsules Recalled for Potential Cross-Contamination

Agency Publication Date: May 6, 2025

Summary

RemedyRePack Inc. has recalled 23 bottles (690 total capsules) of Clindamycin HCl (300 mg), an antibiotic used to treat bacterial infections. The recall was issued because the capsules were repackaged in a facility shared with Ezetimibe tablets, which may have resulted in manufacturing deviations. This recall affects 30-count bottles distributed in Pennsylvania, Virginia, and Florida.

Risk

The shared manufacturing environment could lead to cross-contamination between different medications. If you have health concerns after using this product, you should contact your doctor or pharmacist immediately.

What You Should Do

This recall affects RemedyRePack Inc. brand Clindamycin HCl Capsules (300 mg) sold in 30-count bottles with NDC 70518-3772-02.
Check your medication bottle for lot numbers B3698036-033125 or B3688703-032625 with an expiration date of 07/31/2026.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional information regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Clindamycin HCl Capsule (300 mg)

Variants: 300 mg, 30 Capsules per bottle

Lot Numbers:

B3698036-033125 (Exp 07/31/2026)

B3688703-032625 (Exp 07/31/2026)

NDC:

70518-3772-02

Repackaged by RemedyRepack Inc.; manufactured in a shared facility with Ezetimibe tablets.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 96764

Status: Active

Manufacturer: RemedyRePack Inc.

Manufactured In: United States

Units Affected: 23 bottles/30 count- 690 capsules

Distributed To: Pennsylvania, Virginia, Florida

Agency Last Updated: November 12, 2025

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects RemedyRePack Inc. brand Clindamycin HCl Capsules (300 mg) sold in 30-count bottles with NDC 70518-3772-02.

Check your medication bottle for lot numbers B3698036-033125 or B3688703-032625 with an expiration date of 07/31/2026.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional information regarding this recall.